Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn's Disease: results from the U-ENDURE long-term extension

被引：0

作者：

D'Haens, G. ^{[1
]}

Louis, E. ^{[2
]}

Loftus, E. V. ^{[3
]}

Regueiro, M. ^{[4
]}

Jairath, V. ^{[5
]}

Magro, F. ^{[6
,7
,8
]}

Nakase, H. ^{[9
]}

Dubcenco, E. ^{[10
]}

Lacerda, A. P. ^{[10
]}

Feng, T. ^{[10
]}

Duncan, B. ^{[10
]}

Wang, T. ^{[10
]}

Ford, S. ^{[10
]}

Anyanwu, S. I. ^{[10
]}

Blumenstein, I. ^{[11
]}

机构：

[1] Univ Amsterdam, Dept Gastroenterol & Hepatol, Med Ctr, Amsterdam, Netherlands

[2] Univ Hosp CHU Liege, Dept Hepatogastroenterol & Digest Oncol, Liege, Belgium

[3] Mayo Clin, Div Gastroenterol & Hepatol, Coll Med & Sci, Rochester, MN USA

[4] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, 9500 Euclid Ave, Cleveland, OH 44195 USA

[5] Western Univ, Dept Med, London, ON, Canada

[6] Univ Porto, Unit Pharmacol & Therapeut, Dept Biomed, Fac Med, Porto, Portugal

[7] Univ Porto, CINTESIS RISE Fac Med, Porto, Portugal

[8] Sao Joao Univ Hosp Ctr, Dept Gastroenterol, Porto, Portugal

[9] Sapporo Med Univ, Dept Gastroenterol & Hepatol, Sch Med, Sapporo, Hokkaido, Japan

[10] AbbVie Inc, N Chicago, IL USA

[11] Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OP10

引用

页码：I17 / I18

页数：2

共 1 条